BD Nano™ 2nd Gen Pen Needles have a unique contoured base to help compensate for too much injection force, a common challenge for patients injecting insulin.
BD Nano™ 2nd Gen Pen Needles are estimated to reduce intramuscular injection risk by 2-8x vs 4mm posted base pen needles.
Intramuscular injections have been shown to lead to increased pain and greater risk of hypoglycemia.
FORMULARY PLAN UPDATE FOR 2024
BD Pen Needles and Insulin Syringes have preferred coverage for Medicare Part D patients.
Consider dispensing BD Nano™ 2nd Gen Pen Needles.
Experience the difference of a contoured needle base.
For nearly 100 years, embecta has been accelerating the journey to better diabetes care. With the creation of the first insulin delivery device, we delivered an innovation that moved the management and treatment of diabetes forward.
This post is related to:
Community / Retail Pharmacy Resources Diabetic Care Long-Term Care Pharmacy Resources
